DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ross C. Donehower, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kliniken Essen - Mitte
Essen, Germany
- Krankenhaus Nordwest
Frankfurt, Germany
- Erasmus Medical Center
Rotterdam, Netherlands
- New Cross Hospital
Wolverhampton, England, United Kingdom
- Beatson Oncology Centre
Glasgow, Scotland, United Kingdom
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Nyu School of Medicine'S Kaplan Comprehensive Cancer Center
New York, New York, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2001
- Primary completion
- —
- Completion
- —
- Last update posted
- 18 Feb 2009
- Registered enrollment
- —
- Registry id
- NCT00024375
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.